The ABLATE Trial: Safety and Efficacy of Cox Maze-IV Using a Bipolar Radiofrequency Ablation System.

BACKGROUND: The Cox Maze-IV procedure (CMP-IV) has replaced the Cox Maze-III procedure as the most common approach for the surgical treatment of atrial fibrillation (AF). The Food and Drug Administration-regulated AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation (ABLATE) trial sought to demonstrate the safety and efficacy of the CMP-IV performed with the Synergy ablation system (AtriCure, Inc, Cincinnati, OH). METHODS: Fifty-five patients (aged 70.5 ± 9.3 years), 92.7% of whom had nonparoxysmal AF, underwent CMP-IV to terminate AF during a concomitant cardiac surgical procedure. Lesions were created using the AtriCure Synergy bipolar radiofrequency ablation system. All patients were seen for follow-up visits after 30 days, 3 months, and 6 months, with 24-hour Holter monitoring at 6 months. Late evaluation was performed by 48-hour Holter monitoring at an average of 21 months. RESULTS: The primary efficacy endpoint, absence of AF (30 seconds or less) at 6-month follow-up off antiarrhythmic medications (Heart Rhythm Society definition), indicated 76% (38 of 50) were AF free (95% confidence interval: 62.6% to 85.7%). The primary safety endpoint, the rate of major adverse events within 30 days, was 9.1% (5 of 55; 95% confidence interval: 3.9% to 19.6%), with 3.6% mortality (2 of 55). Secondary efficacy endpoints included being AF free with antiarrhythmic drugs (6 months, 84%; 21 months, 75%), successful pulmonary vein isolation (100%), and AF burden at 6 and 21 months. The results, together with those for the secondary safety endpoint (6-month major adverse events), demonstrated that the Synergy system performs comparably to the cut-and-sew Cox Maze-III procedure. CONCLUSIONS: The CMP-IV using the AtriCure Synergy system was safe and effective for cardiac surgical patients who had persistent and longstanding persistent AF.

Tungiasis--a cause of painful feet in a tropical traveller.

Tungiasis is an ectoparasitosis caused by the impregnated female sand flea Tunga penetrans. It is endemic in certain resource poor areas around the world and imported infestations in travellers can lead to considerable morbidity. With the rise in international travel and immigration, the likelihood of physicians encountering such tropical skin infestations is rising. The ability of physicians to recognise tungiasis early will be immensely beneficial to patients. We describe a case of tungiasis where a traveller presented with painful foot lesions. The patient had returned to the United Kingdom 4 days previously after spending 4 weeks in the Pantanal region in Brazil. A literature review on this subject was undertaken in this article.

Musculoskeletal disorders in dentists.

Occupational injuries involving musculoskeletal tissues are often related to repetitive movements of upper limbs and prolonged postures such as sitting and standing--activities common in dentistry. Surveys of the incidence of musculoskeletal disorders among dentists are few, but in Nebraska, 29 percent of more than 1,000 dentists reported symptoms of peripheral neuropathy in the upper limbs or neck. The Nebraskan dentists reported that crown and bridge work was most likely to evoke altered sensations in their upper limbs. Furthermore, since 47 percent of carpal tunnel syndrome cases in the general population are work-related and are often associated with repetitive motions, it is reasonable to suspect that dentists may be at risk for this musculoskeletal disorder. And, since it is estimated that 60 percent to 80 percent of adults will experience low back pain at one time or another, resulting in it being the second leading cause of absences from work in the general population, dental practitioners are most likely to be among those susceptible to this problem. This article focuses on two ailments afflicting dentists: carpal tunnel syndrome and low back pain.